A similar effect of Smad2 on tumor angiogenesis was reported in breast cancer cells, in which Smad2 suppressed the expression of vascular endothelial growth factor A, a crucial promoter of tumor angiogenesis (72). Here, VEGFA is linked to neoplasm.